CortexIDPET and PET-CT are used routinely to chart neurological degenerative disease processes. But region-specific statistical analysis alone may obscure distributed disease processes and vulnerabilities of other cortical regions. And how does the progression of your patient’s disease compare with age-stratified normals?

CortexID provides easy, robust and clinically validated review/analysis of PET and PET-CT neuro scans. With it, you can compare images that you obtain with images from age stratified normals and patient groups, revealing brain functions that may be altered by the disease processes. It gives you a basic review of any PET neuro scan by providing a general reorientation of the scan volume to standard neurological orthogonal views along the Intercomissural AC-PC line.


  • Structure-function analysis with PET-CT.
  • Fusion and Multi-plane reformat.
  • Proven robust analysis method.
  • Interactive inverse triangulation from 3D SSP to original PET images. 
  • Effortless comparison to previous PET, PET-CT, or MRI.
  • Customizable, interactive reporting tool. 


  • Quantitative assessments in one minute.
  • Effortless comparison of prior PET, CT, or MR studies.
  • Automatic fusion of PET-CT images for functional and structural analysis.
  • Completely automated 3D SSP processing. 
  • Automated normalization to account for differences in acquisition parameters or injected dose. 
  • Qualitative review allows you to detect anatomical abnormalities, cortical uptake patterns.
  • Z-score surface review includes right and left lateral views, medial views, anterior/posterior views, and superior/inferior views.
  • Workflow is easy and intuitive, from image loading to saving and restoring results. 
  • Features a customizable interactive reporting tool.
  • Offers a variety of report-saving options. 

Intended Use

CortexID software option for AW workstation is used to display and analyze PET neurology images acquired on a dedicated PET or hybrid PET/CT scanner.

CortexID is designed to help clinicians quantify pathologies detected with PET and PET-CT brain scans. The software aids in the assessment of human brain scans by providing automated analysis through quantification of the comparison of local peak activity values, at standardized anatomical locations, with the corresponding reference normal peak activity in age- stratified control subjects. The resulting quantification is presented through 3D Stereotactic Surface Projection maps of the brain. CortexID lets the user generate information on the relative changes in metabolic activity between a subject's images and age-stratified controls measured by FDG PET. These relative changes could be the result of brain function alterations by neurodegenerative processes. 

CT Fusion to PET offers visualization of structural abnormalities, such as subdural hematoma, tumor, stroke, or cerebrovascular disease, which may result from brain injury, trauma, disorder, disease or dysfunction. CortexID may help clinicians rule out certain processes.

Image Gallery